Clinical trials for preventing post stroke cognitive impairment.

Area of Science:

• Neurology
• Geriatrics
• Cardiovascular Medicine

Background:

• Post stroke dementia (PSD) affects up to 40% of patients, often co-occurring with Alzheimer's disease.
• The combination of stroke and dementia significantly increases morbidity and mortality.
• Current evidence on preventing cognitive decline post-stroke is limited.

Purpose of the Study:

• To review the current evidence on preventing cognitive decline and dementia after stroke.
• To explore potential therapeutic strategies, including blood pressure management and pharmacological interventions.
• To highlight the need for large-scale trials to establish definitive treatment guidelines.

Main Methods:

• Literature review of existing clinical trials and biological plausibility studies.
• Analysis of evidence regarding blood pressure reduction and its impact on cognitive function.
• Exploration of other potential drug classes, such as cholinesterase inhibitors and SSRIs.

Main Results:

• Limited trial evidence suggests that lowering high blood pressure may reduce the incidence of cognitive decline, vascular dementia, and PSD.
• The optimal magnitude of blood pressure reduction and specific drug classes for efficacy remain unclear.
• Several other drug classes show biological plausibility for preventing cognitive decline post-stroke.

Conclusions:

• Preventing cognitive decline and dementia following a stroke is a critical unmet need.
• Further large-scale definitive trials are essential to determine effective interventions.
• Comprehensive strategies targeting vascular risk factors and exploring novel pharmacological agents are warranted.